Načítá se...
Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke
Hyperhomocysteinemia or systemic elevation of the amino acid homocysteine is a common metabolic disorder that is considered to be a risk factor for ischemic stroke. However, it is still unclear whether predisposition to hyperhomocysteinemia could contribute to the severity of stroke outcome. This re...
Uloženo v:
| Vydáno v: | Exp Neurol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7856041/ https://ncbi.nlm.nih.gov/pubmed/33278453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2020.113541 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|